Halifax’s STI Technologies Launches Medication App for Patients

Halifax-based healthcare company STI technologies has launched an iOS app that promotes personal healthcare management and improve adherence to prescribed medications. It’s part of the company’s “InnoviCares” program, which is a free membership-based patient benefit program that provides financial coverage on many medications and healthcare products. It’s partly funded through partnerships with several pharmaceutical manufacturers

The new app gives members a digital version of their card and provides them with useful features, like easily actionable prescription refill alerts.   These reminders are based on real intelligence driven from prescription possession data.

“Our hope is that Canadians take prompt and proper action when managing their healthcare. Adherence to prescribed medications equals better patient outcomes and reduced overall costs. The innoviCares iPhone app is a simple tool that can assist patients in this regard,” said Dave Gallson of Mood Disorders Society of Canada.


Other notable features include a pharmacy locator that maps the nearest preferred pharmacy that can serve the patient best, as well as personalized benefits and savings and an up-to-date list of what products are covered on the card. Patients simply bring their innoviCares card to their pharmacy when filling a prescription and the card works similar to their drug insurance card, providing coverage on participating products.

The innoviCares program was launched early this year, and 400,000 members are already using the program across Canada. There are currently over 55 different products covered on the program, including diabetes products, chronic pain medications and cancer drugs, along with dozens of other original brand name medications such as Imovane, Wellbutrin XL, Crestor, Nexium, Pantoloc, and Altace. It’s provided at no cost and patients can get a card by visiting www.innovicares.ca.

In late September BetaKit reported on STI Technologies when the company raised a huge $17 million funding round. It was a private equity deal from Imperial Capital Group, a transaction that represented one of the largest investments recently made in the region.

0 replies on “Halifax’s STI Technologies Launches Medication App for Patients”